Clinical Trials in New York

Showing 19881-19900 of 22,668 trials

Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia

NCT00008164

RATIONALE: Umbilical cord blood or placental blood transplantation may be able to replace immune cells that were destroyed by the chemotherapy or radiation therapy that was used to kill cancer cells. PURPOSE: Phase II trial to study the effectiveness of umbilical cord blood and placental blood transplantation in treating patients who have hematologic cancer or aplastic anemia.

Childhood Langerhans Cell HistiocytosisLeukemiaLymphoma+3 more

Herbert Irving Comprehensive Cancer Center30 participantsStarted Jan 1997

New York, New York, United States

COMPLETEDPhase 3< 1 mile

Eflornithine in Treating Patients With Bladder Cancer

NCT00003814

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if eflornithine is more effective than no further therapy in treating bladder cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of eflornithine in treating patients who have newly diagnosed or recurrent bladder cancer.

Bladder Cancer

National Cancer Institute (NCI)450 participantsStarted Feb 1999

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Anaheim, California, United States +58 more locations

Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia

Eflornithine in Treating Patients With Bladder Cancer

Find Trials by Condition in New York

Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Beta Alethine in Treating Patients With Myeloma

Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia

Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder

Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)

Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors

REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable Stent

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf®

Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Interventional Management of Stroke (IMS) III Trial

Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder

Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial

A Study to Evaluate Insulin in the Blood After Inhalation of a Dry Powder Insulin Formulation (Called Technosphere®/Insulin) in Non-diabetic Patients With & Without Chronic Obstructive Pulmonary Disease (COPD)